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Abstract
Migraine can be sub-classified not only according to presence of migraine aura (MA) or absence of migraine aura (MO), but
also by additional features accompanying migraine attacks, e.g. photophobia, phonophobia, nausea, etc. all of which are
formally recognized by the International Classification of Headache Disorders. It remains unclear how aura status and the
other migraine features may be related to underlying migraine pathophysiology. Recent genome-wide association studies
(GWAS) have identified 12 independent loci at which single nucleotide polymorphisms (SNPs) are associated with migraine.
Using a likelihood framework, we explored the selective association of these SNPs with migraine, sub-classified according to
aura status and the other features in a large population-based cohort of women including 3,003 active migraineurs and
18,108 free of migraine. Five loci met stringent significance for association with migraine, among which four were selective
for sub-classified migraine, including rs11172113 (LRP1) for MO. The number of loci associated with migraine increased to 11
at suggestive significance thresholds, including five additional selective associations for MO but none for MA. No two SNPs
showed similar patterns of selective association with migraine characteristics. At one extreme, SNPs rs6790925 (near
TGFBR2) and rs2274316 (MEF2D) were not associated with migraine overall, MA, or MO but were selective for migraine sub-
classified by the presence of one or more of the additional migraine features. In contrast, SNP rs7577262 (TRPM8) was
associated with migraine overall and showed little or no selectivity for any of the migraine characteristics. The results
emphasize the multivalent nature of migraine pathophysiology and suggest that a complete understanding of the genetic
influence on migraine may benefit from analyses that stratify migraine according to both aura status and the additional
diagnostic features used for clinical characterization of migraine.
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Introduction
Migraine is one of the most common and debilitating
neurological disorders and its clinical presentation can be quite
variable [1]. Even when the diagnosis of migraine meets consensus
criteria and can in most cases be clearly distinguished from other
types of headaches (e.g. tension-type headache), phenotypic
heterogeneity in migraine persists [2,3]. The most pronounced
heterogeneity in migraine is the dichotomous sub-classification
according to the presence (MA) or absence (MO) of aura, which
most commonly manifests as a visual disturbance that generally
precedes an attack of headache fulfilling the criteria for migraine.
Other characteristics that may be used to sub-classify migraine are
features of the migraine attack, including pulsatile pain character,
unilateral pain, photophobia, phonophobia, attack duration,
nausea, aggravation by physical activity, severity that inhibits
daily activities, and finally the frequency of attacks. The
International Classification of Headache Disorders (ICHD)
acknowledges all these characteristics either as diagnostic criteria
for migraines or to distinguish different forms of migraine [4].
Although our understanding of the migraine and aura pathophys-
iology has substantially improved [5], many details of migraine
aura and the role of other migraine features remain unclear.
The heterogeneity of migraine characteristics raises both a
challenge and opportunity for using genetics to understand
migraine pathophysiology. While the power to detect genetic
associations will be degraded by potential misclassification due to
the heterogeneity of the clinical presentation, associations that are
selective for migraine with certain characteristics may help reveal
detailed biological causes of migraine, and anticipate the potential
of gene-based migraine classification and treatment. Genetics is
known to be an important determinant of migraine with
heritability estimated in the range 30–60%; and the heritability
for MA is estimated somewhat higher than for MO [6–10]. Recent
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reports have described a greater number of highly significant
common genetic variants for MO than MA in genome-wide
analyses, as well as only partial overlap between the sets of
identified genes [11–13]. One possible explanation of the apparent
discrepancy between heritability estimates and yield of genome-
wide significant associations may be different genetic contributions
to MA v. MO with, for example, the former possibly characterized
by genetic variants that are rarer or more population specific, or
more heterogeneous compared with the latter [14,15]. Similarly, it
is possible that a dichotomy in the genetic architecture may
underlie the additional features that often accompany migraine
headache, i.e. nausea, photophobia, etc.
Here we apply a likelihood-based analytic framework [16] to
explore the possibility of preferential associations with sub-
classified migraine in a population-based cohort of women for
12 single nucleotide polymorphisms (SNPs) arising in recent
genome-wide association studies (GWAS) for migraine overall,
MO, or MA [13]. Enforcing strict significance thresholds, we find
that five SNPs are associated with migraine in our cohort among
which four had selective association with sub-classified migraine.
At suggestive significance, 11 loci were associated with migraine
and all but one displayed selective association with sub-classified
migraine. However, none of the patterns of selective association
according to aura status or the other characteristics was shared by
more than one SNP. The findings suggest that the recently
reported genetic variants influence the underlying pathophysiology
of migraine in very different ways.
Results
Among the Women’s Genome Health Study (WGHS) partic-
ipants of European ancestry with available genetic data, there
were 3,003 women who reported active migraine at baseline,
defined as migraine experienced in the year prior to enrollment,
compared with 18,108 who had never experienced migraine
(Table 1). An additional 2,119 reported having experienced
migraine previously but not in the preceding year and thus were
not sub-classified according to migraine characteristics. These
participants were excluded from the main analysis. Compared
with non-migraineurs, active migraineurs tended to be younger,
have higher BMI, be more likely to use hormone replacement
therapy but less likely to smoke. Thirty nine percent (N = 1,177) of
the WGHS participants with active migraine reported aura,
compared with 61% (N = 1,826) who did not (Table 2). The
prevalence of features associated with migraine ranged from 34%
for pain aggravated by physical activity to 78% for duration of 4–
72 hours.
Applied to 12 SNPs (Table S1) recently reported with genome-
wide association [13], the statistical model selection procedure
with the Bayesian information criterion (BIC) penalty (see
Methods for model selection approach) identified six SNPs with
evidence for migraine association in the WGHS displaying
selectivity according to one or more of the characteristics
accompanying a migraine attack (Table 3). To estimate the
significance of the models selected for each combination of SNP
and migraine sub-classification, an empirical approach was used to
control for multiple hypothesis testing (see Methods). In particular,
permutation of genotype assignments to individuals was used to
estimate: 1) for each combination of SNP and migraine sub-
classification, the probability of selecting a ‘‘non-null’’ model
among six models tested with the BIC (Table S2A), 2) for each
combination of SNP and migraine sub-classification, an empirical
p-value for the analytic log-likelihood (LLR) test of the BIC
selected model (Table S2B), and 3) an overall p-value for each
SNP correcting the empirical p-value in 2) for model selection
across all 10 migraine sub-classifications (Table S2C). The
empirical p-values selecting a non-null model for each combina-
tion of SNP and migraine subtype were in the range 0.0002–
0.0066. For 2), the six SNPs with ‘‘non-null’’ BIC-selected model
for at least one migraine sub-classification had LLR tests with a
maximum empirical p-value 0.0032 before correction for multiple
testing, among which the five excluding rs13208321 (FHL5) were
significant after correcting for testing across the 10 migraine sub-
classifications (‘‘*’’ symbol, Table 3). SNP rs7577262 (TRPM8) was
significantly associated with migraine, correcting for testing across
all 10 sub-classifications, but displayed no selectivity for any of the
migraine-associated characteristics. The remaining four signi-
ficant SNPs were selective for one or more migraine associated
characteristics. For example, SNP rs1172113 (LRP1) was prefer-
entially associated with the migraine without aura, i.e. MO
(‘‘inverse subset’’), and also for migraine with duration 4–72 hours
(‘‘subset’’). Models distinguishing status of the other characteristics
except pulsatile pain were selected for at least one of the SNPs
meeting significance thresholds for multiple testing. However,
none of the characteristics showed selective association shared by
all SNPs.
Model selection with the Akiake information criterion (AIC)
penalty was less stringent, identifying selective associations
according to migraine characteristics for all SNPs except
rs7577262 (TRPM8) (Table 4). The greater number of non-null
models could be explained by the more permissive model selection
found in permutation analysis that estimated the fraction of non-
null models by chance in the range 0.16–0.35 (Table S3A).
Nevertheless, all SNPs except rs10915437 (near AJAP1) had at
least one model with nominally significant empirical p-value for
the LLR test (i.e. ,0.05), and the same five SNPs that had
empirically significant LLR tests in the BIC model selection were
also significant in the AIC model selection, although in some cases
different models were selected (Tables 4 & S3 A, B, C). Thus, for
Author Summary
Migraine is among the most common and debilitating
neurological disorders. Diagnostic criteria for migraine
recognize a variety of symptoms including a primary
dichotomous classification for the presence or absence of
aura, typically a visual disturbance phenomenon, as well as
others such as sensitivity to light or sound, and nausea,
etc. We explored whether any of 12 recently discovered
genetic variants associated with common migraine might
have selective association for migraine sub-classified by
aura status or nine additional migraine features in a
population of middle-aged women including 3,003 mi-
graineurs and 18,180 non-migraineurs. Five of the 12
genetic variants met the most stringent significance
criterion for association with migraine, among which four
had selective association with sub-classified migraine,
including one that was selective for migraine without
aura. At suggestive significance, all of the remaining
genetic variants were selective for sub-classifications of
migraine although no two variants showed the same
pattern of selectivity. The selectivity patterns suggest very
different contributions to migraine pathophysiology
among the 12 loci and their implicated genes. Further,
the results suggest that future discovery efforts for new
migraine susceptibility loci would benefit by considering
associations with sub-classified migraine toward the
ultimate goals of more specific diagnosis and personalized
treatment.
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SNP rs10504861 (near MMP16), the AIC selected the ‘‘inverse
subset’’ model for aura (i.e. MO) and a ‘‘basic’’ model for migraine
characterized by aggravation by physical activity, inhibition of
daily activities, or attack frequency $6/year compared with the
BIC selected ‘‘null’’ model for these characteristics. Similarly, SNP
rs13208321 (FHL5) was identified as ‘‘null’’ with BIC model
selection but as ‘‘inverse subset’’ for aura by the AIC as well as
‘‘subset’’ for other features. Additional differences at the five SNPs
included selection of ‘‘general’’ rather than ‘‘subset’’ models for
phonophobia and migraine attack frequency $6/year at
rs12134493 (TSPAN), and ‘‘general’’ rather than ‘‘basic’’ or
‘‘subset’’ models respectively for phonophobia and aggravation
by physical activity at rs2651899 (PRDM16). Some of the
remaining SNPs had AIC-selected models with nominally
significant empirical LLR p-values (Table S3B), although none
of these models was significant after correction for multiple testing
(Table S3C). Nevertheless, the nominally significant selective
models highlighted additional differences compared with the BIC
penalized analysis, among which ‘‘inverse subset’’ models for aura
(i.e. MO) were selected at rs9349379 (PHACTR1) and rs6478241
(ASTN2).
Using the same BIC and AIC model selection methodology,
there were few differences in the SNP associations between the
3,003 active migraineurs and the 2,119 former migraineurs who
were excluded from the current analysis due to lack of information
related to migraine sub-classification (Table 5). With the BIC
penalty, four SNPs were assigned ‘‘non-null’’ models, all of which
were of the ‘‘basic’’ type, implying no statistical difference in SNP
association between active and former migraine status. With the
AIC penalty, five additional SNPs were assigned ‘‘non-null’’
models and only one, rs10504861 (near MMP16), displayed
preferential association suggesting stronger association with active
migraine.
To examine the model selection results in more detail, the
association effects of each SNP for migraine sub-classified
according to presence or absence of each characteristic were
estimated by logistic regression (Table S4) and depicted in Figure 1.
To aid in presentation of the results, SNPs were ordered according
Table 1. Demographic characteristics of the WGHS according to migraine status.
active migraine# no migraine# p*
N 3,003 18,108
Age (yrs) 51.5 (48.4–55.9) 53.3 (49.1–59.7) ,0.001
Height (inches) 65 (63.0–66.0) 65 (63.0–66.0) 0.45
BMI (kg/m2) 25.0 (22.6–28.4) 24.9 (22.5–28.3) 0.03
Ever smoking 1,375 (45.8%) 8,953 (49.5%) 2.061024
BP (5 category) 0.14
SBP,120 mmHg, DBP,75 1,004 (33.7%) 6,041 (33.8%)
SBP,130, DBP,85 989 (33.2%) 5,787 (32.4%)
SBP,140, DBP,90 555 (18.7%) 3,340 (18.7%)
SBP,160, DBP,95 352 (11.8%) 2,354 (13.2%)
SBP.=160, DBP.= 95 75 (2.5%) 365 (2.0%)
Hormone replacement therapy use 1,434 (47.9%) 7,723 (42.7%) ,0.001
History of diabetes 55 (1.8%) 481 (2.7%) 0.01
#median (inter-quartile range) or N (%).
*p-value from t-test (continuous variables) or chi-square test (categorical variables).
doi:10.1371/journal.pgen.1004366.t001
Table 2. WGHS active migraineurs (N = 3,003*) with aura or migraine characteristic.
Migraine characteristic yes – N (fr.) no – N (fr.)
aura 1,177 (0.39) 1,826 (0.61)
pulsating pain 1,591 (0.53) 1,412 (0.47)
unilateral pain 1,791 (0.60) 1,212 (0.40)
phonophobia 1,232 (0.41) 1,771 (0.59)
photophobia 1,976 (0.66) 1,027 (0.34)
duration of 4–72 hours 2,348 (0.78) 655 (0.22)
nausea 1,958 (0.65) 1,045 (0.35)
pain aggravation by physical activity 1,017 (0.34) 1,986 (0.66)
inhibition of daily activities 1,499 (0.50) 1,504 (0.50)
migraine attack frequency $6/year 1,050 (0.35) 1,953 (0.65)
*An additional 2,119 WGHS participants reported prior but not active migraine compared with 18,172 WGHS participants reported never experiencing migraine.
doi:10.1371/journal.pgen.1004366.t002
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to clustering based on the normalized differences in the association
effects for migraine accompanied with or without the character-
istics (Fig. S1). The clustering thus juxtaposed SNPs with
approximately similar patterns of selectivity across aura status
and the other migraine-associated characteristics. At the top of
Figure 1, SNPs rs7577262 (TRPM8), rs11172113 (LRP1),
rs6478241 (ASTN2), rs10915437 (near AJAP1), and rs9349379
(PHACTR1) form a cluster with relatively less pronounced dif-
ferences in association by stratum status of the migraine-associated
characteristics. In particular, associations with SNP rs7577262
(TRPM8) displayed associations essentially undifferentiated by
stratum status, as reflected also by exclusively BIC-selected ‘‘basic’’
models (Table 2 and Fig. 1, boxes with heavy dotted outline). SNP
rs11172113 (LRP1) in this group had mostly undifferentiated
associations, except for stratum-specific associations according to
aura status (for MO, beta [SE] = 0.14 [0.036], p = 8.36105
compared with MA, beta [SE] = 0.057 [0.043], p = 0.19) and
migraine duration 4–72 hours (beta [SE] = 0.12 [0.032],
p = 0.00012) but not duration under four hours (beta
[SE] = 0.054 [0.058], p = 0.34), as reflected also by ‘‘inverse
subset’’ and ‘‘subset’’ models with the BIC (boxes with heavy solid
outline in Fig. 1), respectively. In the middle of Figure 1, SNPs
rs10504861 (near MMP16), rs13208321 (FHL5), rs2651899
(PRDM16), and rs12134493 (near TSPAN2) all show significant
associations for migraine sub-classified according to one or more
of the migraine characteristics. These findings are consistent with
corresponding ‘‘subset’’ and or ‘‘inverse subset’’ models from the
BIC (Table 4). The remaining three SNPs have a mixture of
stratum independent and stratum specific associations that
differentiate them from the other two clusters. Throughout the
array additional differences in the association effects according to
stratum status are observed for many SNPs as again reflected also
in the ‘‘subset’’ or ‘‘inverse-subset’’ models from the AIC model
selection (Table 5), for example the differences according to aura
status at rs9349379 (PHACTR1) and rs6478241 (ASTN2) as above
rs10915437 (near AJAP1), and rs13208321 (FHL5).
Only two SNPs, rs6790925 (near TGFBR2) and rs2274316
(MEF2D), were found to have ‘‘null’’ models for stratification
according to aura status, and inspection of the beta coefficients
(Fig. 1, Table S4) suggested additional qualitative differences from
the other SNPs. In spite of the very small effects on MA and MO,
and essentially no association with active migraine overall, both
SNPs had appreciable and significant associations for migraine
accompanied by one or more of the characteristics, even showing
significant protective association for rs6790925 and migraine
without nausea (beta [SE] =20.095 [0.048], p = 0.047) and
without photophobia (beta[SE] =20.044[0.037], p = 0.23), or
for rs2274316 and migraine without pulsation (beta[SE] =2
0.062[0.042], p = 0.14), although only the first of these combina-
tions was significant. These patterns of association are consistent
with the ‘‘general’’ models (dashed line, Fig. 1) that were selected
with the AIC penalty and are characterized by different SNP allele
frequencies in all three sub-groups, i.e. unaffected individuals
as well as migraineurs either accompanied or not with the
characteristics.
Discussion
Examining the 12 SNPs recently discovered for association with
migraine, we demonstrated significant preferential associations
with MO compared to MA at high stringency for one SNP
(rs11172113, LRP1) and at lower stringency for five SNPs. Of
these, only rs10504861 (near MMP16), had been discovered
initially in an association analysis specifically targeting MO. Four
additional SNPs had no evidence of selectivity for aura status in
their associations with migraine. SNP rs7577262 (TRPM8) in
particular was highly significant for association with active
migraine but not selective for aura or any of the other
characteristics. It is perhaps relevant that TRPM8, the candidate
gene for this SNP, is thought to mediate the sensation of pain
rather than specific neurological or vascular functions that might
more directly differentiate the pathophysiology of the migraine
sub-classes [17]. The final two SNPs were not associated with
active migraine, MA, or MO but were associated with migraine
accompanied by one or more of the other migraine-specific
characteristics, implying that these characteristics may be more
relevant to the underlying pathophysiologic consequences of these
genetic variants than aura status. Among the candidate functions
for loci other than TRPM8, PRDM16 has roles in cardiac
development [18] and directing developmental cell fates toward
Table 5. Testing selective association for active (N = 3,003) compared with former migraineurs (N = 2,119).
model selected*
SNP chr:pos (b. 37) genomic context BIC AIC
rs2651899 1:3083711 PRDM16 basic basic
rs10915437 1:4183005 near AJAP1 - -
rs12134493 1:115677945 near TSPAN2 basic basic
rs2274316 1:156446241 MEF2D - -
rs7577262 2:234818868 TRPM8 basic basic
rs6790925 3:30480084 near TGFBR2 - -
rs9349379 6:12903956 PHACTR1 - basic
rs13208321 6:96860353 FHL5 -. basic
rs4379368 7:40466199 C7orf10 - basic
rs10504861 8:89547931 near MMP16 - sub.
rs6478241 9:119252628 ASTN2 - basic
rs11172113 12:57527282 LRP1 basic basic
*model definitions as in Tables 3 and 4.
doi:10.1371/journal.pgen.1004366.t005
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brown fat or skeletal muscle [19], SNPs near the matrix
metalloproteinase gene MMP16 have been associated at ge-
nome-wide significance with psychiatric conditions [20] and non-
syndromic cleft lip [21], and LRP1, encoding the LDL receptor-
related protein 1 with molecular functions in endocytosis in several
settings, has been implicated by GWAS in lipid homeostasis [22],
lung function [23], abdominal aortic aneurysm [24], and transport
of beta-amyloid in the brain [25]. The function of TSPAN2, the
final candidate gene with BIC-selective association in the WGHS,
is largely unknown, but it belongs to the tetraspanin family that
has been linked to signal transduction [26]. Thus, the genetic
architecture of migraine appears to reflect a multivalent patho-
physiology and, from the dual perspectives of statistical power and
understanding biology, association strategies that rely on the
conventional dichotomy according to aura status may not be the
sole or even best approach for genetic dissection of migraine.
Instead, the patterns of selective association with migraine
accompanied by the non-aura characteristics may be at least as
important to understanding migraine pathophysiology as the
selectivity toward aura. All of the SNPs (except rs7577262)
displayed some selectivity according to the non-aura characteris-
tics that commonly accompany migraine, at least with the AIC
penalty, and there was at least one SNP with a selective association
for each characteristic even with the BIC penalty, which enforced
a very high stringency in model selection. No pair of SNPs shared
an identical patter of subtype associations. The selective associa-
tions are likely not to reflect, trivially, the contribution of the
WGHS population to discovery of the candidate SNPs since sub-
classification of migraine was not used in the original discovery.
Moreover, the WGHS contribution to the main discovery analysis
in the previous study [13] included a total of 5,122 migraineurs, as
the combination of the 3,003 active migraineurs analyzed here
and an additional 2,119 WGHS participants who reported having
had migraine in their life but not in the year prior to enrollment.
Thus, the migraineurs in the present analysis are a subset of those
used in the published meta-analysis, even as the WGHS
contributed approximately one-fifth of the total cases in that
study. Only rs10504861 (near MMP16) in the previous analysis
was identified exclusively in a previous sub-analysis restricted to
MO and therefore including only the 1,826 WGHS MO cases
rather than the 5,122 cases with history of any migraine. In
contrast, rs10915437 (near AJAP1) and rs6790925 (near TGFBR2)
were discovered exclusively among clinic-based samples, excluding
the WGHS altogether. However, rs11172113 (LRP1) rather than
rs10504861 was identified as an MO-specific in the analysis using
the BIC penalized model selection. Thus, the design of the
previous discovery meta-analysis is expected to confer only
minimal bias at most in the selectivity of associations presented
here, especially selective associations identified with the BIC
penalty and those identified for sub-classifications other than the
MA v. MO dichotomy.
There has been a suggestion that migraineurs who remit, i.e.
appear to no longer experience migraine, may have different
underlying pathophysiology from those who do not. This dif-
ference may have a partial genetic basis that might extend to
differences in the selective associations reported here. Our data do
not allow exploration of this possibility directly since migraineurs
who did not report active migraine in the WGHS at baseline were
not sub-classified according to aura status or the other migraine
characteristics. However, we note that model selection for SNP
associations with active compared with former migraine status
suggested that the associations with overall migraine in the two
groups were largely similar. The exception was rs10504861 (near
MMP16) that displayed selective associations using the stringent
BIC (Table 3) and also a preferential association with active
compared with former migraineurs (Table 5).
One potential, though ultimately not robustly supported,
explanation of the subtype associations might be that they simply
reflect associations among individuals suffering a greater severity
of migraine rather than selectivity for specific features. If this were
the case, then one would expect that selectivity patterns might be
highly correlated, perhaps especially with associations according to
strata for migraine attack frequency, one measure of migraine
severity. However, these patterns were not observed. First, the
patterns of selective associations are not shared by any of the
SNPs. Second, some SNPs show no selectivity (i.e. ‘‘basic’’ model)
for migraine attack frequency$6/year but selectivity (i.e. ‘‘subset’’
or ‘‘inverse subset’’ models) for other characteristics, for example
aura status (rs11172113 [LRP1], rs6478241 [ASTN2], rs13208321
[FLH5], rs10504861 [near MMP16]). Finally, among SNPs where
there is a selective association with migraine characterized by
attack frequency $6/year, there are few similarities among the
associations with sub-classification based on the other character-
istics. For example, rs12134493 (near TSPAN2), which is highly
selective for migraine with attack frequency $6/year, also shows
selectivity for unilateral pain, phonophobia, and photophobia, but
not for pulsation, duration of 4–72 hours, aggravation by physical
activity, and inhibition of daily activities, all features that show
selective association with other SNPs, including SNPs that are also
selective for high frequency migraine.
Several strengths and limitations should be considered when
interpreting our results. Strengths include the large, homogeneous
population-based sample of middle-aged women of European
ancestry who were apparently healthy at study entry, as enforced
specifically by a lack of overt CVD or cancer at baseline. Thus, the
WGHS is very well-powered for the migraine sub-classification
analysis presented here and further represents an age range in
which migraine is relatively prevalent. Limitations include the self-
reported nature of migraine and sub-phenotypes, which may result
in misclassification. Other, comparably ascertained and well-
powered cohorts that also include ascertainment of migraine sub-
phenotypes and genotype information are not readily available
and this circumstance limited our ability to replicate the analysis.
Instead, we used a permutation procedure to establish significant
thresholds consistent with multiple hypothesis testing. The study
also does not address genetic associations with sub-classified
Figure 1. Estimates (beta coefficients) for association in the WGHS from logistic models for each of the 12 candidate SNPs as
predictors of migraine accompanied by aura or other characteristics (black bars), or not (gray bars). Significant associations are
indicated with ‘‘*’’ (see also Table S4). Model selection results (Tables 3 & 4) are indicated with outlines around each plot as follows: Non-null models
selected using the BIC are indicated with a heavy red outline, while non-null models selected using the AIC are indicated with a thin black outline.
‘‘Subset’’ or ‘‘inverse subset’’ models (see Methods) are indicated with a solid outline, ‘‘basic’’ models are indicated with a dotted outline, and
‘‘general’’ models are indicated with a dashed outline. Migraine characteristics considered were aura, pulsating pain ( = pulsate), unilateral pain
( = unipain), phonophobia ( = sound), photophobia ( = light), duration of 4–72 hours ( = longdur), nausea, aggravation by physical activity
( = aggrphys), inhibition of daily activities ( = inhibit), $6 attacks/year ( = freq). The rightmost column (actmig) indicates association estimates for
active migraineurs, irrespective of status for the characteristics (see Methods). The order of SNPs is derived from clustering as in Figure S1. See also
Methods.
doi:10.1371/journal.pgen.1004366.g001
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migraine in other groups including women younger than 45, men,
or children, nor does it address explicitly the genetic underpin-
nings of sub-classification in migraine with a strong familial
inheritance pattern. Further targeted studies are warranted to
address these issues.
The selective genetic associations with sub-classified migraine
provide a glimpse into the future possibility of resolving some of
the heterogeneity in migraine. Sub-classification of migraineurs
according to combinations of migraine-associated characteristics
potentially representing more clinically homogeneous sub-groups
has been suggested as one approach [2,27]. However, sub-groups
of migraineurs cannot be unambiguously defined based on discrete
patterns of co-occurrence of migraine-associated characteristics.
Because of this ambiguity, applying the present statistical
methodology to test for selective genetic associations with such
sub-groups is much more complex than analyses based on
individual migraine characteristics. In considering alternative
approaches to solving the complex presentation and pathophys-
iology of migraine, ongoing research experience in the genetics of
psychiatric disorders may be relevant. Psychiatric disorders are
notoriously difficult to diagnose, a challenge that also extends to
devising optimal treatment. Attempts to classify psychiatric
disorders on the basis of clinical symptoms alone, as for example
by the updated diagnosis criteria in the recently published DSM-5,
are controversial [28,29]. At the same time recent genome-wide
genetic analyses have revealed both different and shared causal
genetic loci across multiple psychiatric disorders with distinct
diagnoses on the basis of clinical presentation alone [30,31]. It is
not hard to imagine that increasingly detailed clinical and genetic
characterization may ultimately coalesce into integrated and more
reliable diagnostic criteria for these psychiatric conditions. Such
combined clinical and genetic strategies for improved classification
may be imagined also for migraine, although they would likely
require establishment of a larger number of genetic loci than the
12 robust loci explored in the current analysis.
Nevertheless, improved classification of migraine may help
identify the most important pathophysiological pathway(s) in a
given migraine patient and may allow for prioritization of
treatment options. In this respect, discovery of more loci and
therefore genes relevant to migraine in future genome-wide studies
may provide further understanding of the complete set of
biological interactions that underlie migraine in its various forms.
Knowledge of these interactions may guide development of novel
therapeutic strategies. The same knowledge may also be translated
toward the ultimate clinical goal of delivering the most individually
targeted therapy in treating migraine.
Methods
Study population
The Women’s Genome Health Study (WGHS). The
WGHS [32] is a large population-based cohort for genetic
analysis and includes individuals who provided a blood sample
at baseline in the Women’s Health Study (WHS) [33,34], a
randomized, placebo controlled trial of aspirin and vitamin E in
primary prevention of cardiovascular disease and cancer among
apparently healthy female healthcare professionals, aged 45 years
or older at baseline in 1992–1995. Migraine in the WHS was
ascertained at baseline by self-report as described previously
[35,36]. Briefly, participants were asked at baseline: ‘‘Have you
ever had migraine headaches?’’ and ‘‘In the past year, have you
had migraine headaches?’’ Responses to these questions were used
to classify participants with no history of migraine, ‘‘active’’
migraine, i.e. migraine experienced within the past year, or
‘‘prior’’ migraine, i.e. migraine experienced more previous to the
past year. Participants reporting active migraine were further
queried for detailed characteristics of their migraine attacks
including: the presence of aura status or premonition of an attack,
the frequency of attacks (e.g. daily, weekly, etc.), the duration of
attacks (4–72 hours), whether attacks were accompanied by
nausea or sensitivity to light or sound, whether the pain had a
unilateral location or a pulsating quality, and whether the pain was
aggravated by physical activity or inhibited daily activity.
Responses to these questions allowed classifications of migraineurs
according to modified ICHD-2 criteria. In a subset of 1,675
participants from the Women’s Health Study, 88% with self-
reported active migraine fulfilled either diagnostic criteria of
migraine without aura (72%) or probable migraine without aura
(16%) [35].
Genotyping in the WGHS was performed with the Illumina
Duo ‘‘+’’ platform as described [32], targeting approximately
317K SNPs that tag common variation (i.e. minor allele frequency
.,5%) in populations of European ancestry and supplemented
by SNPs to provide dense coverage of candidate genes for
cardiovascular disease and related conditions as well as SNPs with
known consequences to health. Retained samples had successful
genotyping across .98% of the SNPs, while retained SNPs had
successful genotyping across .90% of the samples. A multidi-
mensional scaling procedure in PLINK [37] was used to identify
the subset of 23,294 WGHS participants with verified self-reported
European ancestry. Within this group, SNPs were excluded if a
test for Hardy-Weinberg equilibrium had p,1026 or minor allele
frequency ,1%, leaving 339,596 SNPs in the final data set.
Genotypes for additional SNPs in HapMap2 (build 36, r. 22) but
not represented on the genotyping array were imputed with
MaCH v. 1.0.16 [38] using the CEU reference population.
Statistical analysis
Candidate SNPs. Statistical modeling was applied to the 12
SNPs identified as the lead associations in a recent large genome-
wide meta-analysis [13]. Nine of these SNPs had genome-wide
significance in meta-analysis incorporating all studies among
which there were a total of 23,285 migraine cases. Of the
remaining three SNPs, rs10915437 (near AJAP1) and rs6790925
(near TGFBR2) had genome-wide significance exclusively in clinic-
based samples and therefore excluding the WGHS. The final SNP,
rs10504861 (near MMP16) was discovered exclusively in a sub-
analysis including only the 6,550 MO cases, including the 1,826
from the WGHS included in this analysis. In the WGHS, SNPs
rs2651899, rs6790925, rs4379368, and rs11172113 were geno-
typed directly. A small number of missing genotypes from these
SNPs and the genotypes at the remaining eight candidate SNPs
were imputed. The quality of imputation was adequate or
excellent for all of these SNPs ranging from R2 values of 0.61
and 0.72 for rs9349379 and rs10915437, respectively, to.0.94 for
the remaining SNPs (Table S1).
Likelihood framework for model selection. For each of
the characteristics accompanying migraine, model selection
compared the Bayesian or Akiake Information Criteria (BIC or
AIC) penalized likelihood for six different inheritance models.
Each inheritance model was specified by SNP minor allele
frequencies in three groups: a) migraineurs experiencing the
characteristic, b) migraineurs not experiencing the characteristic,
and c) non-migraineurs. Following previously published method-
ology [16], the six possible models were 1) the ‘‘null’’ model,
meaning that there was no SNP association with migraine, and
specified by the same allele frequency in all three groups (1 degree
of freedom [df]); 2) the ‘‘basic’’ model, meaning that the SNP was
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associated with migraine overall, and specified by one allele
frequency among migraineurs regardless of the presence of the
characteristic and a different allele frequency among non-
migraineurs (2df); 3) the ‘‘subset’’ model, meaning that the SNP
was associated with migraine sub-classified according to the
presence of one of the characteristics, and specified by one allele
frequency among migraineurs experiencing the characteristic and
a different but identical minor allele among migraineurs not
experiencing the characteristic and non-migraineurs (2df); 4) the
‘‘inverse subset’’ model, meaning that the SNP was associated with
migraine sub-classified by the absence of one of the characteristics,
and specified by one allele frequency among migraineurs not
experiencing the characteristic and a different but identical minor
allele among migraineurs experiencing the characteristic and non-
migraineurs (2df); 5) the ‘‘general’’ model, meaning that the SNP
had different magnitude of association with migraine sub-classified
by the presence and the absence of one of the characteristics, and
specified by different minor allele frequencies in all three groups
(3df); and 6) the ‘‘modifier’’ model, specified by different minor
allele frequencies among migraineurs experiencing the character-
istic or not experiencing the characteristic, and the weighted mean
of the two frequency estimates among non-migraineurs (2df). The
‘‘modifier’’ model describes an association with the migraine
characteristic among migraineurs but not between migraineurs
and non-migraineurs, i.e. an association with the characteristic
conditional on having migraine. The significance of the selected
association model for each combination of SNP and migraine
associated characteristic was evaluated by the p-value for the
standard log-likelihood ratio (LLR) test statistic comparing the
likelihood of a selected model with the likelihood of the null model,
i.e. assuming the negative of twice the difference in the likelihoods
had chi-squared distribution with degrees of freedom equal to
twice the difference in the degrees of freedom of the two models
under the null.
Empirical significance estimates. Empirical significance
estimates of the BIC and AIC model selection procedures were
derived through a permutation approach. In order to simulate null
distributions, the entire BIC and AIC model selection procedures
were repeated after random reassignment of SNP genotypes to
WGHS participants 10,000 times. For each combination of SNP
and migraine characteristic, the probability of selecting a non-null
model was estimated as the fraction of non-null models with the
permuted data. Similarly, an empirical p-value for the LLR test of
the selected model for each combination of SNP and migraine
characteristic was estimated as the fraction of LLR test analytic p-
values among models from the permutations less than or equal to
the observed analytic p-value for a given combination of SNP and
migraine characteristic. The permutations were also used to adjust
the significance of model LLR tests for multiple hypotheses testing
using rank statistics. Thus, for each SNP, a stage 1 correction was
made by computing the fraction of permuted results with the
smallest LLR test analytic p-value across all 10 migraine
characteristics less than or equal to the observed smallest analytic
LLR test p-value. Similarly, the second smallest LLR test p-value
for that SNP was corrected by computing the fraction of permuted
results with second smallest LLR test analytic p-value across all 10
migraine characteristics less than or equal to the observed second
smallest LLR test analytic p-value for that SNP. The process was
repeated for all 10 LLR test p-values for each SNP. These rank
adjusted p-values were then corrected in a second stage using the
Sˇida´k procedure assuming 12 independent SNPs.
Effect estimates and cluster analysis. SNP effect estimates
(beta coefficients) from logistic regression were computed for the
association of each SNP with migraine either accompanied or not
with each of the characteristics compared with non-migraineurs.
The choice of coded allele in the logistic models was assigned as
the allele associated with increased probability of any report of
migraine in the WGHS population overall at baseline (Table S1).
SNPs were clustered according to vectors of the differences in
the beta coefficients for migraine with or without each of the
characteristics, normalized by the square root of the sum of the
squared standard errors, i.e. a t-statistic. The Mahalanobis metric
was used to define a distance between each pair of SNP vectors
while addressing the potential for correlation structure due to
overlap of the migraine characteristics. The covariance of the
vector entries for the migraine characteristics in the Mahalanobis
analysis was derived from association testing using 1,222
independent SNPs not associated with migraine from the GWAS
catalog ([39] available at www.genome.gov/gwastudies, accessed
3/13/2013). Hierarchical clustering was performed with the
function ‘‘hclust’’ in R [40].
Ethics statement. All data collection and reported research
complies with international guidelines and was approved by the
Institutional Review Board (IRB) of Brigham and Women’s
Hospital.
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